SCHEMBL24690561

SCHEMBL24690561

NCC(=O)N[C@@H](C[C@@H]1CCNC1=O)C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23824437 0.86 CTSL (0.37) —
SCHEMBL23824440 0.86 CTSL (0.37) —
SCHEMBL23824442 0.86 CTSL (0.37) —
SCHEMBL23506393 0.85 CTSL (0.39) —
SCHEMBL30823567 0.83 NOD1 (0.41) —
SCHEMBL24690554 0.82 — —
SCHEMBL21702235 0.81 CTSL (0.42) —
SCHEMBL23836465 0.81 CTSL (0.36) —
SCHEMBL25134601 0.81 CTSL (0.36) —
SCHEMBL24696826 0.81 CTSL (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022256434-A1 PROTEASE INHIBITORS AS ANTIVIRALS ACEA Therapeutics, Inc. (US) 2022-12-08 — — WO disclosed
Send feedback